Clinical Trials on Metastatic Castration-resistant Prostate Cancer (CRPCa)
Total 1162 results
-
Accelerated Community Oncology Research NetworkBayerTerminatedMetastatic Prostate CancerUnited States
-
SanofiTerminatedMetastatic Prostate CancerBrazil
-
Cytogen CorporationUnknownMetastatic Prostate CancerUnited States
-
Jeanne LinkOregon Health and Science University; OHSU Knight Cancer Institute; OHSU Center...Approved for marketingProstatic Neoplasms | Prostatic Diseases | Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
-
Brigham and Women's HospitalDana-Farber Cancer Institute; Blue Earth DiagnosticsNot yet recruitingMetastatic Prostate Cancer | Hormone Sensitive Prostate Cancer | Metastatic Hormone-sensitive Prostate Cancer (mHSPC)United States
-
M.D. Anderson Cancer CenterRecruitingMetastatic Renal Cell Carcinoma | Metastatic Melanoma | Castration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Bone | Metastatic Urothelial... and other conditionsUnited States
-
Peter Busch ØstergrenRecruitingProstate Cancer MetastaticDenmark
-
Dana MathewsCompletedProstate Cancer | Prostate Cancer MetastaticUnited States
-
Sun Pharmaceutical Industries LimitedCompleted
-
University of California, San FranciscoCompletedMetastatic Prostate CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.UnknownProstate Cancer MetastaticChina
-
Advanced Accelerator ApplicationsCompletedProstate Cancer MetastaticUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedPhase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate CancerMetastatic Prostate CancerUnited States
-
ImaginAb, Inc.CompletedMetastatic Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
University of Michigan Rogel Cancer CenterExelixisTerminatedProstate Cancer MetastaticUnited States
-
Burzynski Research InstituteTerminatedMetastatic Prostate CancerUnited States
-
Astellas Pharma Europe Ltd.Terminated
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Kuopio University... and other collaboratorsCompletedMetastatic Prostate CancerFinland
-
SanofiCompletedProstate Cancer MetastaticIndia
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
DexTech Medical ABCompletedProstate Cancer MetastaticSweden
-
Bristol-Myers SquibbCompletedMetastatic Prostate CancerUnited States
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Korea, Republic of, Japan
-
The Netherlands Cancer InstituteBayerCompletedBone Metastases | Prostate Cancer MetastaticNetherlands
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingMetastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Castration-Sensitive Prostate CarcinomaUnited States
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
National Cancer Institute (NCI)Enrolling by invitationProstatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Prostate Neoplasms | Prostatic CancerUnited States
-
AstraZenecaScandinavian Prostate Cancer GroupCompletedNon-Metastatic Prostate CancerSweden, Finland, Norway, Denmark
-
AstraZenecaCompletedNon-Metastatic Prostate CancerFinland
-
Celsee DiagnosticsWithdrawnMetastatic Prostate Cancer, CTC
-
AstraZenecaCompletedNon-metastatic Prostate CancerUnited States, Canada
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
Trans Tasman Radiation Oncology GroupBayer; Peter MacCallum Cancer Centre, AustraliaRecruitingAdvanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSAAustralia, Singapore
-
AmgenCompletedCastrate-resistant Prostate CancerUnited Kingdom, Czech Republic
-
Stanford UniversityNational Cancer Institute (NCI)CompletedMultiple Myeloma | Recurrent Prostate Cancer | Plasmacytoma | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Hellenic Cooperative Oncology GroupSanofiCompletedBone Metastatic Prostate CancerGreece
-
University of WashingtonJanssen Scientific Affairs, LLCRecruitingCastration-Resistant Prostate Carcinoma | Prostate AdenocarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingProstatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Cancer Of Prostate | ProstateUnited States
-
Progenics Pharmaceuticals, Inc.CompletedStudy of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (CONDOR)Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States, Canada
-
National Cancer Institute (NCI)Enrolling by invitationProstate Cancer | Metastatic Prostate Cancer | Cancer Of Prostate | Prostate Neoplasms | Prostatic CancerUnited States
-
University Hospital, GhentRecruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | OligometastasisBelgium
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.; Medivation, Inc.; Biologics...Active, not recruitingRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States, Canada, Puerto Rico
-
Chang Gung Memorial HospitalRecruiting
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.TerminatedMetastatic Prostate CancerUnited States
-
Institut Paoli-CalmettesNovartisTerminatedNon Castrate Metastatic Prostate CancerFrance
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Oregon Health and Science UniversityCompletedProstate Cancer | Metastatic, Androgen Independent Prostate CancerUnited States